• Home
  • The Science
  • Our Technology
  • About Us
  • Resources
    • Educational Webinars
    • News
    • Video
    • #HOPE4LIVER
  • Let’s Talk

Josh Stopek, PhD

February 10, 2020

Share this!
News

HistoSonics Announces First Ever Kidney Tumor Treatment Using Histotripsy

HistoSonics announced today the first kidney patient has been treated using the Company's histotr...

Read more

News

HistoSonics Announces FDA Approval of its Pivotal IDE #HOPE4KIDNEY Trial

HistoSonics announced today the US Food and Drug Administration (FDA) has approved the company sp...

Read more

The HistoSonics System is not yet commercially available and is for investigational use only. Final performance specifications and claims are subject to change pending the completion of regulatory market-access activities.

  • Privacy Policy
  • Terms of Use

© 2019-2023 HistoSonics®. All rights reserved.